SetPoint Medical Receives $15,000,000 Series C Funding Round

  • Feed Type
  • Date
    9/8/2015
  • Company Name
    SetPoint Medical
  • Mailing Address
    28368 Constellation Rd. Valencia, CA 91355 USA
  • Company Description
    SetPoint Medical is a biomedical technology company developing neuromodulation therapies for patients with inflammatory autoimmune diseases, such as rheumatoid arthritis and Crohn’s Disease. The company’s scientific platform is based on the Inflammatory Reflex—the natural mechanism by which the central nervous system regulates the immune system. SetPoint co-founder Kevin Tracey discovered the Inflammatory Reflex pathway, publishing his findings in the journal Nature in May 2000.
  • Website
    http://www.setpointmedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds from the financing will be used to support the company’s clinical trials to assess safety and efficacy of its bioelectronic therapy in rheumatoid arthritis (RA) and Crohn’s Disease, and to help advance the therapy toward commercialization.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy